Skip to main content
Print This Page
Text Size
Scroll To Top
Share This Page
Share this page on Facebook
Share this page on Linkedin
Share this page on X/Twitter
Member Login
ADD ME TO THE EMAIL LIST
JOIN TODAY
menu
Home
About
About CEPA
Membership
CEPA Leadership
Strategic Partners
Code of Ethics
FAQ
Contact Us
Advocacy
Education
Annual Conference 2025
eLearning
Event Calendar
Other Continuing Ed
Annual Conference 2024
Annual Conference 2023
Member Resources
Become an FCEPA
Discussion Forums
Internship Directory
Job Share & Mbr Spotlight
Legislative Resources
Membership Directory
National Provider ID
Public
Publications
JCEP (member access)
JCEP (public view)
Salary Surveys
Home
Abstract submission 2025
CEPA'S 2025 ANNUAL ONLINE CONFERENCE
- Call for Abstracts -
Abstracts Being Accepted Until November 15th, 2024
All accepted abstracts will be highlighted in the CEPA Annual Meeting final program and published in the
Journal of Clinical Exercise Physiology
.
Recorded slide presentations will be posted on the CEPA 2025 Annual Meeting webpage.
Previously presented abstracts or content from manuscripts that has been published will not be considered.
The first author will receive of accepted abstracts will receive
FREE conference registration
.
Early investigator award available to individuals who graduated with a bachelor's or master's degree within 5 years.
Scientific Abstract Size and Presentation
The abstract length must be ≤ 3,000 characters (excluding the title and authors).
Abstracts should be single-spaced, with no additional line space between paragraphs.
Neither figures nor tables are permitted.
Abstracts will be reduced in size when edited for publishing, so all lettering/symbols/lines should be clear and distinct.
Abstract Format
Use capital letters for the abstract title and the presenting author's name and affiliation.
Additional authors and their affiliations should be typed in title-case. Provide only the highest degree for each author.
For research abstracts, the following subheadings should be used: INTRODUCTION, METHODS, RESULTS, CONCLUSIONS.
For case study abstracts, the following subheadings should be used: INTRODUCTION, CASE PRESENTATION, MANAGEMENT or OUTCOME, DISCUSSION.
Define all abbreviations the first time they appear in the abstract.
Use only generic names of drugs.
Do not include citations/references.
Proofread the abstract prior to submitting. You will not have the opportunity to revise your abstract after it has been submitted.
Grading of Submissions
Abstracts will undergo a blinded review by the Conference Planning Committee based on scientific and/or clinical merit and overall presentation. Authors and institutions will be removed to permit anonymous scoring by the committee.
Notification of acceptance will be sent to the corresponding author in December 2024 via email.
Submitting an Abstract
Abstracts must be submitted through the CEPA website (link below).
The abstract submission fee must be paid through the CEPA website (link below).
Refunds will not be provided.
The submission deadline is November 15, 2024.
SUBMIT YOUR ABSTRACT